Medtech
    August 9, 2025
    7 min read

    Turn Your CE Marking Into Investor Interest, Market Buzz, and Customer Leads — Before the Moment Passes

    If you treat CE marking as the finish line for PR, you'll miss one of the most powerful growth moments you'll ever have. Learn how to turn regulatory approval into investor interest, market buzz, and customer leads.

    Own the Policy Moment: A Cleantech Founder's Guide to Timing PR for Maximum Growth

    šŸŒ Every time climate policy shifts, buyers, investors, and journalists are all asking the same thing:

    "Who has the solution to make this real?"

    Founders who can answer that question in the heat of the moment don't just get headlines — they win partnerships, close funding faster, and shape how their market sees them.

    The problem? Most cleantech startups miss the window.

    They either announce too early (before details are confirmed) or too late (when the story has moved on).

    Here's how to make sure you're in the headlines and on the shortlists that matter — every time climate policy news breaks.

    Why CE Marking Is More Than Compliance

    For a medtech scaleup, CE marking is more than a stamp of approval — it's a market signal.

    It tells:

    Investors — "We've cleared regulatory risk. We're ready to scale."

    Partners — "You can integrate or distribute us in Europe starting now."

    Customers — "We're safe, effective, and available."

    Handled right, your CE marking can:

    • Shorten sales cycles by reducing buyer hesitation
    • Unlock investor conversations that previously stalled
    • Attract inbound partnership requests from distributors, clinics, and strategic players

    The 2-Week Prep + 48-Hour Execution Plan

    The worst time to write your CE marking press release is after you've received it.

    The founders who win this moment have their story, assets, and outreach list ready in advance so they can move instantly.

    2 Weeks Before Approval (Preparation Phase)

    • Draft your press release in full, with flexible wording for the exact approval date.
    • Prepare founder and clinical leader quotes that balance clinical credibility with commercial vision.
    • Create all supporting visuals — product shots, infographics, short explainer video.
    • Build your tiered media list: investor media, industry trade, and local business press.
    • Draft LinkedIn and email announcement copy for company + team profiles.
    • Identify "friendly journalists" who already know your story and can move fast.
    • Offer background briefings to journalists so they're primed for the announcement.
    šŸ’” Pro Tip: Getting your media list right is half the battle — know exactly who you'll call before the day arrives.

    48 Hours After Approval (Execution Phase)

    Hour 1–6

    • Update your pre-written release with the final approval date/details.
    • Alert your internal team, board, and investors so they can share from their networks.
    Hour 6–24

    • Distribute to your pre-built media list.
    • Call top-priority journalists — don't rely on email alone.
    • Offer quick interviews with your founder or medical lead.
    Hour 24–48

    • Publish on your website, LinkedIn, and in relevant industry communities.
    • Share media coverage links (not just your press release) for social proof.
    • Thank journalists who covered you and engage with their posts.

    Positioning Your CE Marking for Maximum Commercial Impact

    When you tell your CE marking story, think like a growth-stage founder, not a regulator.

    Your story should answer:

    The Problem — What's broken in the current patient or provider experience?

    The Solution — How does your innovation solve it in a way nothing else does?

    The Timing — Why now? Tie it to trends, policy, or market shifts.

    The Proof — What data, trials, or results got you approved?

    The Future — How big is the opportunity now that Europe is open to you?

    šŸ’” Pro Tip: The best coverage comes when journalists can see how your story fits into a bigger industry trend.

    Where to Be Seen

    Different audiences require different channels:

    For Investors

    • Sifted, TechCrunch, local business press, VC-focused newsletters
    For Buyers & Partners

    • MedTech Europe outlets, HealthTech Wire, Medical Device Network
    For Industry Peers

    • Specialty journals and trade publications in your device category

    Avoid These Founder PR Pitfalls

    Waiting Weeks to Announce — Momentum dies and your story gets buried.

    Overloading on Jargon — Keep the focus on market impact and patient outcomes.

    Skipping Visuals — Words alone won't get you front-page trade coverage.

    Forgetting the Business Angle — Always link to growth, investment, and market expansion.

    From Milestone to Momentum

    A CE marking isn't a one-day headline — it's the start of a growth PR roadmap.

    • Month 0: CE marking announcement
    • Month 1: First EU commercial partnerships
    • Month 2: Clinical outcomes data release
    • Month 3: Market expansion announcement
    • Month 4: Customer case study
    • Month 5: Funding round or strategic partnership
    By spacing these announcements, you stay in the conversation and keep your momentum building.

    How Heartspace Can Help

    At Heartspace, we help Nordic medtech scaleups turn moments like CE marking into:

    • Coverage that builds investor confidence
    • Stories that open partnership doors
    • Visibility that drives leads
    With our Guaranteed Coverage model, you'll always walk away with published articles — whether through earned media or native placements — so your milestone never goes unnoticed.

    šŸ“… to map your CE marking PR plan, or explore our medtech PR solutions.

    Written by

    Sohrab Fadai
    Sohrab Fadai

    Co-founder & CEO

    Nirvana Gharni
    Nirvana Gharni

    Co-founder & Head of Marketing

    Tags

    medtechCE markingregulatoryPR strategyNordic

    Ready to Get Started?

    Get expert PR guidance tailored to your medtech startup.